Morgan Stanley analyst Kristine Liwag raised the firm’s price target on Northrop Grumman (NOC) to $720 from $625 and keeps an Overweight rating on the shares. Defense Primes are poised to report Q3 earnings amidst one of the longest government shutdowns in history, which does not make it easy for management teams to guide to 2026 with clarity, the analyst tells investors. However, the firm would be buyers of tepid Defense outlooks as upward revisions should materialize as the funding picture clears up, adds the analyst, whose Top Pick in Defense remains Northrop.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOC:
- Here’s What Top RBC Capital Analyst Expects from U.S. Defense Stocks Ahead of Q3 Earnings
- Private Markets: AI model startup Reflection AI raises $2B
- Gold tops $4,000, SoftBank buys robotics unit: Morning Buzz
- Intel, FedEx downgraded: Wall Street’s top analyst calls
- Deutsche upgrades Northrop Grumman to Buy ahead of Q3 report